Medication info

Dapagene Tablets 5mg (Dapagliflozin Anhydrous Mixture)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›7.635mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Yellow, biconvex, round film-coated tablet
Packaging
28 Tablets/PTP[(7 Tablets/PTP×4, 14 Tablets/PTP×2)]
Approval status
Expired

MFDS item code 202005361 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug therapy for diabetes, when this medicine is administered in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar regulation disorders
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This drug is used along with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in conjunction with other medications. It is particularly helpful in cases where blood sugar control is difficult, and it can be cautiously applied to patients with cardiovascular diseases or risk factors. For detailed information, please refer to professional clinical trial information. This drug is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug therapy for diabetes, when this medicine is administered in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Precautions

This drug should not be used in patients who are allergic to the active ingredients or excipients of this drug. It is also not safe to administer to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this drug as it contains anhydrous lactose. Patients undergoing dialysis should also not use this drug. Caution should be exercised when administering to patients with low fluid volume or poor kidney function. This drug can cause hypotension or worsen kidney function due to reduced intravascular volume; therefore, assessment of fluid status and kidney function must be performed before administration. After administration, symptoms of hypotension and changes in kidney function should be regularly monitored. This drug contains specific dyes, Yellow No. 4 and Yellow No. 5, and should be used cautiously in patients with allergies or a history of hypersensitivity to these components. During the course of taking this drug, genital infections or urinary tract infections may occur, so immediate treatment is necessary if symptoms of infection arise. There may also be symptoms of hypoglycemia, so dosage adjustments may be needed when taken with insulin or sulfonylureas to reduce the risk of hypoglycemia. Dehydration symptoms or dry mouth may occur due to decreased fluid volume, so adequate fluid intake and symptom monitoring are important. In severe cases, drug administration may be temporarily suspended. This drug may increase the risk of diabetic ketoacidosis; therefore, if symptoms of ketoacidosis such as vomiting, abdominal pain, or difficulty breathing occur, immediate medical attention is required. Elderly patients or those with reduced kidney function may be particularly sensitive to side effects of this drug and require careful management and monitoring. It is advisable for pregnant or breastfeeding women to avoid using this drug, and if pregnancy is confirmed, administration should be immediately stopped. There is no specific antidote for overdose, so appropriate treatment and observation are required based on symptoms. This drug does not significantly affect driving or machinery operation, but caution is needed due to the risk of hypoglycemia.

Side effects

  • Vulvovaginitis
  • balanitis
  • genital infection
  • urinary tract infection
  • fungal infection
  • perineal necrosis
  • hypoglycemia
  • decrease in fluid volume
  • thirst
  • diabetic ketoacidosis
Show 184 more
  • dizziness
  • constipation
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • increased blood urea
  • weight loss
  • acute pyelonephritis
  • rash
  • angioedema
  • asthenia
  • pain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral arterial occlusion
  • angina
  • myocardial infarction
  • biliary stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • sensory disturbance
  • cerebral infarction
  • nerve compression
  • urosepticemia
  • acute kidney injury
  • upper abdominal pain
  • diverticulosis
  • intestinal perforation
  • acute pancreatitis
  • chronic pancreatitis
  • hyperglycemia
  • sensory decrease
  • headache
  • nasopharyngitis
  • upper respiratory infection
  • edema
  • fever
  • foreign body sensation
  • facial edema
  • facial pain
  • warmth
  • influenza-like symptoms
  • breast mass
  • erectile dysfunction
  • benign prostatic hyperplasia
  • breast pain
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • vulvar discomfort
  • menstrual irregularity
  • hair loss
  • dermatitis
  • xerosis
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • hyperhidrosis eczema
  • dyshidrotic eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • urticaria
  • cold sweat
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteopenia
  • muscle weakness
  • contusion
  • road traffic accident
  • drug overdose
  • ankle fracture
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • hand fracture
  • pelvic fracture
  • laceration
  • ligament tear
  • limb injury
  • meniscus injury
  • skin abrasion
  • tendon rupture
  • thoracic vertebra fracture
  • tibia fracture
  • dental injury
  • dry eye
  • eye pain
  • retinal disorder
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • glaucoma
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • voice disorders
  • epistaxis
  • obstructive sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • flushing
  • peripheral coldness
  • varices
  • vascular headache
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorder
  • nocturia
  • auditory hallucinations
  • sleep disorders
  • fatty liver
  • gallbladder polyp
  • vertigo
  • anal genital warts
  • gastric adenoma
  • neuroma
  • pituitary neoplasm of uncertain behavior
  • male hypogonadism
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • erythrocytosis
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • alanine aminotransferase increase
  • aspartate aminotransferase increase
  • decreased appetite
  • hyperosmia
  • dysgeusia
  • headache
  • edema
  • chest pain
  • fatigue
  • chest discomfort
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • pruritus
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • palpitations
  • insomnia
  • tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius to preserve the drug's efficacy and safety for longer periods.

Appearance and packaging

Appearance

Yellow, biconvex, round film-coated tablet

Package unit

28 Tablets/PTP[(7 Tablets/PTP×4, 14 Tablets/PTP×2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.